Collagenase-1 (MMP-1) activity in equine synovial fluid: Influence of age, joint pathology, exercise and repeated arthrocentesis

Equine Veterinary Journal

Volumn 36, Issue 1, 2004, Pages 34-40

  Brama, P A J ^a   Van Den Boom, R ^a   DeGroot, J ^b   Kiers, G H ^b   Van Weeren, P R ^a  

^a Faculty of Veterinary Medicine   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Age; Arthrocentesis; Collagenase 1 (MMP 1); Exercise; Horse; Joint pathology

Indexed keywords

COLLAGENASE; COLLAGENASE 1; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AGING; ANIMAL TISSUE; ARTHROCENTESIS; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; EXERCISE; FLUORESCENCE; HORSE; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; REOPERATION; STATISTICAL SIGNIFICANCE; SYNOVIAL FLUID;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 2542537635     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/0425164044864705     Document Type: Article

References (55)

1. Aimes, R.T. and Quigley, J.P. (1995) Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyses the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J. Biol. Chem. 270, 5872-5876.
2. Balkman, C.E. and Nixon, A.J. (1998) Molecular cloning and gene expression of equine stromelysin 1 (matrix metalloproteinase 3). Am. J. vet. Res. 59, 30-36.
3. Bank, R.A., Soudry, M., Maroudas, A., Mizrahi, J. and TeKoppele, J.M. (2000) The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation. Arthritis Rheum. 43, 2202-2210.
4. Beekman, B., Drijfhout, J.W., Bloemhoff, W., Ronday, H.K., Tak, P.P. and TeKoppele, J.M. (1996) Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Letters 390, 221-225.
5. Beekman, B., van El, B., Drijfhout, J.W., Ronday, H.K. and TeKoppele, J.M. (1997) Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay. FEBS Letters 418, 305-309.
6. Beekman, B., Drijfhout, J.W., Ronday, H.K. and TeKoppele, J.M. (1999) Fluorogenic MMP activity assay for plasma including MMPs complexed to alpha 2-macroglobulin. Ann. NY Acad. Sci. 878, 150-158.
7. Birkedal-Hansen, H., Moore, W.G.I., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J.A. (1993) Matrix metalloproteinases: a review. Crit. Rev. oral Biol. Med. 4, 197-250.
8. Borden, P., Solymar, D., Swcharczuk, A., Lindman, B., Cannon, P. and Heller, R.A. (1996) Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J. Biol. Chem. 271, 23577-23581.
9. Brama, P.A.J., TeKoppele, J.M., Beekman, P.R., van Weeren, P.R. and Barneveld, A. (1998) Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis. Ann. Rheum. Dis. 57, 697-699.
10. Brama, P.A.J., TeKoppele, J.M., Beekman, B., van El, B., Barneveld, A. and van Weeren, P.R. (2000) Influence of development and joint pathology on stromelysin activity in equine synovial fluid. Ann. Rheum. Dis. 59, 155-157.
11. Brown, T. and Shaw, D. (1984) In vitro contact stress distribution on the femoral condyles. J. orthop. Res. 2, 190-199.
12. Chubinskaya, S., Huch, K., Mikecz, K., Cs-Szabo, G., Hasty, K.A., Kuettner, K.E. and Cole, A.A. (1996) Chondrocyte matrix metalloproteinase-8: upregulation of neutrophil collagenase by interleukin-1-beta in human cartilage from knee and ankle joints. Lab. Invest. 74, 232-240.
13. Clark, I.M., Powell, L.K., Ramsey, S., Hazleman, B.I. and Cawston, T.E. (1993) The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 36, 372-379.
14. Clegg, P.D., Coughlan, A.R., Riggs, C.M., and Carter, S.D. (1997a) Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine vet. J. 29, 343-348.
15. Clegg, P.D., Burke, R.M., Coughlan, A.R., Riggs, C.M. and Carter, S.D. (1997b) Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints. Equine vet. J. 29, 335-342.
16. DeGroot, J., Verzijl, N., Budde, M., Bijlsma, J.W.J., Lafeber, F.P.J.G. and TeKoppele, J.M. (2001) Accumulation of advanced glycation end products decreases collagen turnover by bovine chondrocytes. Expt. Cell Res. 266, 303-310.
17. DiBattista, J.A., Pelletier, J.P., Zafarullah, M., Iwata, K. and Martel-Pelletier, J. (1995) Interleukin-1-beta induction of tissue inhibitor of metalloproteinase (TIMP-1) is functionally antagonized by prostaglandin E2 in human synovial fibroblasts. J. Cell Biochem. 57, 619-629.
18. Drijfhout, J.W., Nagel, J., Beekman, B., TeKoppele, J.M., and Bloemhoff, W. (1996) Solid phase synthesis of peptides containing the fluorescence energy transfer Dabcyl-Edans couple. In: Peptides: Chemistry, Structure and Biology, Eds: P.T.P. Kaumaya and R.S. Hodges, Mayflower Scientific, London. pp 129-131.
19. Fell, H.B., Barratt, M.E., Welland, H. and Green, R. (1976) The capacity of pig articular cartilage in organ culture to regenerate after breakdown induced by complement-sufficient antiserum to pig erythrocytes. Calcif. Tissue Res. 20, 3-21.
20. Firestein, G.S., Paine, M.M. and Littman, B.H. (1991) Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Arthritis Rheum. 34, 1094-1105.
21. Huebner, J.L., Otterness, I.G., Freund, E.M., Caterson, B. and Kraus, V.B. (1998) Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Arthritis Rheum. 41, 877-890.
22. Ishiguro, N., Ito, T., Ito, H., Iwata, H., Jugessur, H., Ionescu, M. and Poole, A.R. (1999) Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover. Analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum. 42, 129-136.
23. James, T., Wagner, R., White, L., Zwolak, R. and Brinckerhoff, C. (1993) Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line. J. Cell Physiol. 157, 426-437.
24. Jubb, R.W. and Fell, H.B. (1980) The breakdown of collagen by chondrocytes. J. Pathol. 130, 159-167.
25. Kafienah, W., Brömme, D., Buttle, D.J., Croucher, L.J. and Hollander, A.P. (1998) Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem. J. 331, 727-732.
26. Kempson, G.E. (1980) The mechanical properties of articular cartilage. In: The Joints and Synovial Fluid, Vol. 2, Ed: L. Sokoloff, Academic Press, New York. pp 177-238.
27. Keyszer, G.M., Heer, A.H., Kriegsmann, J., Geiler, T., Trabandt, A., Keysser, M., Gay, R.E., and Gay, S. (1995) Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum. 38, 976-984.
28. Knight, C.G., Willenbrook, F. and Murphy, G. (1992) A novel coumarin labeled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Letters 296, 263-266.
29. Lohmander, L.S., Hoerrner, L.A. and Lark, M.W. (1993) Metalloproteinases, tissue inhibitors, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 36, 181-189.
30. Lohmander, L.S., Lark, M.W., Dahlberg, L., Walakovits, L.A. and Roos, H. (1992) Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine. Clin. Biochem. 25, 167-174.
31. Lohmander, L.S., Dahlberg, L., Eyre, D., Lark, M., Thonar, E.J. and Ryd, L. (1998) Longitudinal and crosssectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities. Osteoarthritis Cartilage 6, 351-361.
32. Maroudas, A. (1976) Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 260, 808-809.
33. Maroudas, A. (1980) Metabolism of cartilaginous tissues: a quantitative approach. In: Studies in Joint Disease, Vol. 1, Eds: A. Maroudas and E.J. Holborow, Pitman Medical, Tunbridge Wells. pp 59-86.
34. Maroudas, A., Palla, G. and Gilav, E. (1992) Racemization of aspartic acid in human articular cartilage. Connect. Tissue Res. 28, 161-169.
35. Matrisian, L.M. (1990) Metalloproteinases and their inhibitors in matrix remodelling. Trends in Genetics 6, 121-125.
36. Mayne, R. (1989) Cartilage collagens: what is their function, and are they involved in articular disease? Arthritis Rheum. 32, 241-246.
37. McAnulty, R.J. and Laurent, G.J. (1990) In vivo measurement of collagen metabolism in cartilage and bone. In: Methods in Cartilage Research, Eds: A. Maroudas and K. Kuettner, Academic Press Inc., San Diego, California. pp 140-142.
38. Mitchell, P.G., Magna, H.A., Reeves, L.M., Lopresti-Morrow, L.L., Yocum, S.A., Rosner, P.J., Geoghegan, K.F. and Hambor, J.E. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. clin. Invest. 97, 761-768.
39. Murphy, G. and Knäuper, V. (1997) Relating matrix metalloproteinase structure to function: why the 'hemopexin' domain? Matrix Biol. 15, 511-518.
40. Murphy, G., Hembry, R.M., Hughes, C.E., Fosang, A.J. and Hardingham, T.E. (1990) Role and regulation of metalloproteinases in connective tissue turnover. Biochem. Soc. Trans. 18, 812-815.
41. Nagase, H. and Woessner, J.F. (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
42. Pap, G., Eberhardt, R., Sturmer, I., Machner, A., Schwarzberg, H., Roessner, A. and Neumann, W. (1998) Development of osteoarthritis in the knee joints of Wistar rats after strenuous running exercise in a running wheel by intracranial selfstimulation. Path. Res. Pract. 194, 41-47.
43. Reboul, P., Pelletier, J.P., Tardif, G., Cloutier, J.M. and Martel-Pelletier, J. (1996) The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not synoviocytes. J. clin. Invest. 97, 2011-2019.
44. Riley, G.P., Curry, V., DeGroot, J., van El, B., Verzijl, N., Hazleman, B.L. and Bank, R.A. (2002) Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 21, 185-195.
45. Roos, H., Dahlberg, L., Hoerrner, L.A. Lark, M.W., Thonar, E.J., Shinmei, M., Lindqvist, U. and Lohmander, L.S. (1995) Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise. Osteoarthritis Cartilage 3, 7-14.
46. Shlopov, B.V., Lie, W., Mainardi, C.L., Cole, A.A., Chubinskaya, S. and Hasty, K.A. (1997) Osteoarthritic lesions. Involvement of three different collagenases. Arthritis Rheum. 40, 2065-2074.
47. Tetlow, L.C., Adlam, D.J. and Woolley, D.E. (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 44, 585-594.
48. Todhunter, R.J. (1996) General principles of joint pathobiology. In: Joint Disease in the Horse, Eds: C.W. McIlwraith and G.W. Trotter, W.B. Saunders Co., Philadelphia. pp 1-28.
49. Trumble, T.N., Trotter, G.W., Thom Oxford, J.R., McIlwraith, C.W., Cammarata, S., Goodnight, J.L., Billinghurst, R.C. and Frisbie, D.D. (2001) Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am. J. vet. Res. 62, 1467-1477.
50. Tung, J.T., Arnold, C.E., Alexander, L.H., Yuzbasiyan-Gurkan, V., Venta, P.J., Richardson, D.W. and Caron, J.P. (2002) Evaluation of the influence of prostaglandin E2 on recombinant equine interleukin-1beta-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures. Am. J. vet. Res. 63, 987-993.
51. van den Boom, R., Brama, P.A.J., Kiers, G.H., DeGroot, J. and van Weeren, P.R. (2004) The influence of repeated arthrocentesis and exercise on general MMP activity and cytokine levels in equine joints. Equine vet. J. In press.
52. Verzijl, N., DeGroot, J., Thorpe, S.R., Bank, R.A., Shaw, J.N., Lyons, T.J., Bijlsma, J.W., Lafeber, F.P., Baynes, J.W. and TeKoppele, J.M. (2000) Effect of collagen turnover on the accumulation of advanced glycation end products. J. Biol. Chem. 275, 39027-39031.
53. Vu, T.H. and Werb, Z. (2000) Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14, 2123-2133.
54. Walter, H., Kawashima, A., Nebelung, W., Neumann, W. and Roessner, A. (1998) Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. Path. Res. Pract. 194, 73-81.
55. Wolfe, G.C., MacNaul, K.L., Buechel, F.F., McDonnell, J., Hoerrner, L.A., Lark, M.W., Moore, V.L. and Hutchinson, N.I. (1993) Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Arthritis Rheum. 36, 1540-1547.